FDA Approves Implantable Device for Urge Urinary Incontinence
The tibial neuromodulation therapy is designed with a 15-year battery life and is MRI-compatible.
The tibial neuromodulation therapy is designed with a 15-year battery life and is MRI-compatible.
The U.S. FDA has proposed banning electrical stimulation devices for self-injurious or aggressive behavior due to significant risks, marking the second attempt at prohibition, with implications including potential treatment transitions for users and a thorough review of updated evidence and expert opinions.
The tibial neuromodulation therapy is designed with a 15-year battery life and is MRI-compatible.